Mingsheng Zhang
No.1095 Jie Fang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Conversion treatment with hepatic arterial infusion of oxaliplatin, leucovorin and fluorouracil plus intravenous bevacizumab or cetuximab for initially unresectable colorectal liver metastasis: A prospective study.
Journal: Cancer treatment and research communications
Published: October 05, 2025
Tumor-suppressing multi-enterobacteria and PD-1/PD-L1 immune checkpoint inhibitor combination improves the outcome of hepatocellular carcinoma therapy.
Journal: Frontiers in immunology
Published: March 23, 2025
Efficacy and safety of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer: a retrospective cohort study.
Journal: Journal of gastrointestinal oncology
Published: March 04, 2022
Effect of Reduced-Dose Capecitabine Plus Cetuximab as Maintenance Therapy for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Clinical Trial.
Journal: JAMA network open
Published: July 21, 2020
Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection.
Journal: BMC endocrine disorders
Published: November 24, 2019
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy.
Journal: Journal of hematology & oncology
Published: January 21, 2019
microRNA-452 exerts growth-suppressive activity against T-cell acute lymphoblastic leukemia.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: December 02, 2017
Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration.
Journal: Oncotarget
Published: June 27, 2017
Last Updated: 09/26/2026